Novartis's Narasimhan faces his first big test | Evaluate
Novartis says it knew of Zolgensma data problems before U.S. approval | The Japan Times
Vas Narasimhan, The Chiefs 35 - Radio | Monocle
247点のNovartis Ceoのストックフォト - Getty Images
Vas Narasimhan | Fortune
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Basel is very open to newcomers - Basel Area Business & Innovation
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Vasant (Vas) Narasimhan, M.D. | African Parks
Novartis CEO in the hotseat after revelation that his company submitted falsified data to the FDA - The Boston Globe
Vas Narasimhan (@VasNarasimhan) / Twitter
It was never my plan to be the boss of a huge company' - BBC News
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times
Novartis Vas Narasimhan – Justin Hession Photography
Vas Narasimhan – The Chiefs Podcast – Podcast – Podtail
Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis | Business Standard News
It was never my plan to be the boss of a huge company' - BBC News
Vas Narasimhan – Chief Executive Officer – Novartis | LinkedIn
BSR Conference 2018 | Vasant Narasimhan | Speakers
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Novartis CEO Narasimhan says he was 'completely blindsided' by Cohen deal revelation | FiercePharma
Vas Narasimhan visiting Ghana / Twitter
